We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Software Detects Osteoporosis from Routine CT Scans

By HospiMedica International staff writers
Posted on 02 Oct 2026

Osteoporosis can progress for years without pain, leaving bone loss undetected until a fracture or back pain prompts testing. More...

By that point, bone loss may already be advanced. Bone density testing is not typically performed until osteoporosis is suspected. To help detect the condition earlier, researchers are developing software that measures bone density from existing computed tomography (CT) scans.

The software, called BMDNow, is being developed by the Fraunhofer Institute for Computer Graphics Research IGD (Darmstadt, Germany) with Goethe University Frankfurt and Garritz Online Media International. It measures bone mineral density in individual vertebrae using CT images acquired for other purposes. This approach does not require an additional scan or specialized equipment.

BMDNow uses neural networks to identify the trabecular region, the spongy tissue inside each vertebral body. An imaging algorithm then analyzes bone components, including fat and calcium, and produces a three-dimensional, color-coded map of density distribution. Calibration curves generated with reference phantom models are used to calculate bone density values that indicate osteoporosis or osteopenia, a precursor to osteoporosis.

The team tested artificial intelligence models under real-world conditions using patient data from Frankfurt University Hospital. The researchers are currently using dual-energy CT scans, which acquire images at two X-ray energy levels, to measure density in individual vertebral bodies. They plan to adapt the algorithms for conventional single-energy CT scans, while finalizing and validating the prototype. Their longer-term plans include a reference database, with medical device approval targeted within one to two years.

“In contrast, our software uses existing routine CT image data—such as from heart or lung scans—without the need for additional specialized examinations. This reduces patients' individual radiation exposure and saves physicians' time,” said Stefan Wesarg, a research scientist at Fraunhofer IGD in Darmstadt. 

“Our algorithm is applied specifically in this inner region of the vertebrae to generate a three-dimensional map of bone density distribution. The AI model analyzes bone components such as fat and calcium and uses color coding to visualize their proportions,” added Wesarg.

Related Links
Fraunhofer IGD


Gold Member
Blood Gas Analyzer
i-Check200
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Multi-Chamber Washer-Disinfector
WD 390
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: WHX returns to Dubai Exhibition Centre, Expo City, and Dubai World Trade Centre from 5–28 January 2027 (Photo courtesy of World Health Expo)

World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.